<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.5"?>
<!-- generated-on="2026-05-26T10:38:48+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.5" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://news.medxy.ai/circulating-microrna-scores-may-distinguish-cellular-and-antibody-mediated-heart-transplant-rejection-with-high-accuracy/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-26T00:27:17-07:00</news:publication_date><news:title>Circulating MicroRNA Scores May Distinguish Cellular and Antibody-Mediated Heart Transplant Rejection With High Accuracy</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e7%b5%8c%e5%8f%a3%e3%82%bb%e3%83%9e%e3%82%b0%e3%83%ab%e3%83%81%e3%83%89%e3%81%a8%e9%ab%98%e3%83%aa%e3%82%b9%e3%82%af2%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e5%bf%83/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-26T00:26:22-07:00</news:publication_date><news:title>経口セマグルチドと高リスク2型糖尿病における心血管リスク因子の変化</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/semaglutide-duong-uong-va-su-thay-doi-cac-yeu-to-nguy-co-tim-mach-o-benh-nhan-tieu-duong-type-2-co-nguy-co-cao/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-26T00:24:49-07:00</news:publication_date><news:title>Semaglutide đường uống và sự thay đổi các yếu tố nguy cơ tim mạch ở bệnh nhân tiểu đường type 2 có nguy cơ cao</news:title></news:news></url>
<url><loc>https://news.medxy.ai/oral-semaglutide-and-cardiovascular-risk-factor-changes-in-high-risk-type-2-diabetes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-26T00:23:17-07:00</news:publication_date><news:title>Oral Semaglutide and Cardiovascular Risk Factor Changes in High-Risk Type 2 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e6%85%a2%e6%80%a7%e5%86%a0%e7%8a%b6%e5%8b%95%e8%84%88%e7%96%be%e6%82%a3%e3%81%ae%e5%a5%b3%e6%80%a7%ef%bc%9apci%e3%81%a8cabg%e5%be%8c%e3%81%ae%e9%95%b7%e6%9c%9f%e4%ba%88%e5%be%8c/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-26T00:16:26-07:00</news:publication_date><news:title>慢性冠状動脈疾患の女性：PCIとCABG後の長期予後</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/phu-nu-mac-benh-dong-mach-vanh-man-tinh-ket-qua-dai-han-sau-pci-so-voi-cabg/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-26T00:15:01-07:00</news:publication_date><news:title>Phụ nữ mắc bệnh động mạch vành mãn tính: Kết quả dài hạn sau PCI so với CABG</news:title></news:news></url>
<url><loc>https://news.medxy.ai/women-with-chronic-coronary-artery-disease-long-term-outcomes-after-pci-vs-cabg/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-26T00:12:57-07:00</news:publication_date><news:title>Women with Chronic Coronary Artery Disease: Long-Term Outcomes After PCI vs CABG</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e6%8b%a1%e5%bc%b5%e5%9e%8b%e5%bf%83%e7%ad%8b%e7%97%87%e3%81%a8%e5%bf%83%e5%be%8b%e5%a4%b1%e5%b8%b8%e6%80%a7%e5%bf%83%e7%ad%8b%e7%97%87%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%80%a7%e5%88%a5%e3%83%bb/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-26T00:09:19-07:00</news:publication_date><news:title>拡張型心筋症と心律失常性心筋症における性別・年齢特異的遺伝的リスク: SHaReレジストリからの洞察</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/nguy-co-di-truyen-theo-gioi-va-tuoi-trong-benh-co-tim-phi-dai-va-benh-co-tim-loan-nhip-nhung-hieu-biet-tu-dang-ky-share/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-26T00:07:25-07:00</news:publication_date><news:title>Nguy cơ di truyền theo giới và tuổi trong bệnh cơ tim phì đại và bệnh cơ tim loạn nhịp: Những hiểu biết từ Đăng ký SHaRe</news:title></news:news></url>
<url><loc>https://news.medxy.ai/sex-and-age-specific-genetic-risk-across-dilated-and-arrhythmogenic-cardiomyopathy-insights-from-the-share-registry/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-26T00:03:59-07:00</news:publication_date><news:title>Sex- and Age-Specific Genetic Risk Across Dilated and Arrhythmogenic Cardiomyopathy: Insights From the SHaRe Registry</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e9%ab%98%e8%84%82%e8%9b%8b%e7%99%bda%e5%9c%a8%e6%97%a0%e6%97%a2%e5%be%80%e5%bf%83%e8%82%8c%e6%a2%97%e6%ad%bb%e6%88%96%e4%b8%ad%e9%a3%8e%e7%9a%84%e6%83%85%e5%86%b5%e4%b8%8b%e6%a0%87%e8%ae%b0/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-25T23:50:39-07:00</news:publication_date><news:title>高脂蛋白(a)在无既往心肌梗死或中风的情况下标记更大的冠状动脉风险，而Evolocumab提供类似的相对益处和更大的绝对获益</news:title></news:news></url>
<url><loc>https://news.medxy.ai/higher-lipoproteina-marks-greater-coronary-risk-without-prior-mi-or-stroke-while-evolocumab-delivers-similar-relative-benefit-and-larger-absolute-gains/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-25T23:46:27-07:00</news:publication_date><news:title>Higher Lipoprotein(a) Marks Greater Coronary Risk Without Prior MI or Stroke, While Evolocumab Delivers Similar Relative Benefit and Larger Absolute Gains</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e8%85%b9%e8%85%94%e5%86%85%e3%81%8a%e3%82%88%e3%81%b3%e9%9d%99%e8%84%88%e5%86%85%e3%83%91%e3%82%af%e3%83%aa%e3%82%bf%e3%82%ad%e3%82%bb%e3%83%ab%e3%81%a8s-1%e3%81%ae%e4%bd%b5%e7%94%a8%e3%81%8c/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-25T23:42:52-07:00</news:publication_date><news:title>腹腔内および静脈内パクリタキセルとS-1の併用が胃癌腹膜転移患者の生存を改善：フェーズ3試験</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/paclitaxel-tiem-vao-o-bung-va-tinh-mach-ket-hop-voi-s-1-cai-thien-su-song-con-trong-ung-thu-da-day-di-can-mang-bung-thu-nghiem-giai-doan-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-25T23:41:28-07:00</news:publication_date><news:title>Paclitaxel tiêm vào ổ bụng và tĩnh mạch kết hợp với S-1 cải thiện sự sống còn trong ung thư dạ dày di căn màng bụng: Thử nghiệm giai đoạn 3</news:title></news:news></url>
<url><loc>https://news.medxy.ai/intraperitoneal-and-intravenous-paclitaxel-plus-s-1-improves-survival-in-gastric-cancer-with-peritoneal-metastasis-phase-3-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-25T23:38:15-07:00</news:publication_date><news:title>Intraperitoneal and Intravenous Paclitaxel Plus S-1 Improves Survival in Gastric Cancer With Peritoneal Metastasis: Phase 3 Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/%e6%8a%97ebv-bnlf2b%e6%8a%97%e4%bd%93%e5%9c%a8%e7%96%91%e4%bc%bc%e9%bc%bb%e5%92%bd%e7%99%8c%e9%97%a8%e8%af%8a%e8%af%8a%e6%96%ad%e4%b8%ad%e6%98%be%e7%a4%ba%e5%87%ba%e9%ab%98%e5%87%86%e7%a1%ae%e6%80%a7/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-05-25T19:50:06-07:00</news:publication_date><news:title>抗EBV BNLF2b抗体在疑似鼻咽癌门诊诊断中显示出高准确性</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/eb%e3%82%a6%e3%82%a4%e3%83%ab%e3%82%b9-bnlf2b-%e6%8a%97%e4%bd%93%e3%80%81%e7%96%91%e3%82%8f%e3%81%97%e3%81%84%e9%bc%bb%e5%92%bd%e9%a0%ad%e3%81%8c%e3%82%93%e3%81%ae%e5%a4%96%e6%9d%a5%e8%a8%ba%e6%96%ad/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-25T19:48:03-07:00</news:publication_date><news:title>EBウイルス BNLF2b 抗体、疑わしい鼻咽頭がんの外来診断で高精度を示す</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/khang-the-chong-ebv-bnlf2b-co-do-chinh-xac-cao-trong-chan-doan-ngoai-tru-ung-thu-vom-hong-nghi-ngo/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-25T19:44:44-07:00</news:publication_date><news:title>Kháng thể chống EBV BNLF2b có độ chính xác cao trong chẩn đoán ngoại trú ung thư vòm họng nghi ngờ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/anti-ebv-bnlf2b-antibody-shows-high-accuracy-for-outpatient-diagnosis-of-suspected-nasopharyngeal-carcinoma/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-25T19:40:27-07:00</news:publication_date><news:title>Anti-EBV BNLF2b Antibody Shows High Accuracy for Outpatient Diagnosis of Suspected Nasopharyngeal Carcinoma</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e7%96%91%e3%82%8f%e3%81%97%e3%81%84%e9%bc%bb%e5%92%bd%e9%a0%ad%e7%99%8c%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8beb%e3%82%a6%e3%82%a4%e3%83%ab%e3%82%b9bnlf2b%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e6%8a%97/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-25T19:25:45-07:00</news:publication_date><news:title>疑わしい鼻咽頭癌におけるEBウイルスBNLF2bに対する抗体の診断性能</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-suat-chan-doan-cua-khang-the-chong-vi-rut-epstein-barr-bnlf2b-trong-u-nhay-mui-hong-nghi-ngo/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-25T19:24:06-07:00</news:publication_date><news:title>Hiệu suất chẩn đoán của kháng thể chống vi-rút Epstein-Barr BNLF2b trong u nhầy mũi họng nghi ngờ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/diagnostic-performance-of-anti-epstein-barr-virus-bnlf2b-in-suspected-nasopharyngeal-carcinoma/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-25T19:21:41-07:00</news:publication_date><news:title>Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/%e6%80%a5%e6%80%a7a%e5%9e%8b%e4%b8%bb%e5%8a%a8%e8%84%89%e5%a4%b9%e5%b1%82%e4%b8%ad%e5%86%b7%e5%86%bb%e8%b1%a1%e9%bc%bb%e6%9c%af%e7%bb%93%e5%90%88%e5%85%a8%e5%bc%93%e7%bd%ae%e6%8d%a2%e6%9c%af%e5%8f%af/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-05-24T13:53:09-07:00</news:publication_date><news:title>急性A型主动脉夹层中冷冻象鼻术结合全弓置换术可提供持久的20年结果和较少的晚期主动脉事件</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e6%80%a5%e6%80%a7a%e5%9e%8b%e5%a4%a7%e5%8b%95%e8%84%88%e8%a7%a3%e9%9b%a2%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e5%86%b7%e5%87%8d%e8%b1%a1%e3%81%ae%e9%bc%bb%e6%89%8b%e8%a1%93%ef%bc%9a20%e5%b9%b4/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-24T13:50:58-07:00</news:publication_date><news:title>急性A型大動脈解離に対する冷凍象の鼻手術：20年間の持続的な結果と半弓置換よりも少ない遅発性大動脈イベント</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/phuong-phap-trunk-voi-dong-bang-cho-boc-tach-cap-tinh-loai-a-dong-mach-chu-mang-lai-ket-qua-ben-vung-trong-20-nam-va-it-su-kien-dong-mach-sau-muon-hon-so-voi-sua-chua-nua-cung/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-24T13:47:33-07:00</news:publication_date><news:title>Phương pháp Trunk voi đóng băng cho bóc tách cấp tính loại A động mạch chủ mang lại kết quả bền vững trong 20 năm và ít sự kiện động mạch sau muộn hơn so với sửa chữa nửa cung</news:title></news:news></url>
<url><loc>https://news.medxy.ai/frozen-elephant-trunk-for-acute-type-a-aortic-dissection-delivers-durable-20-year-outcomes-and-fewer-late-aortic-events-than-hemiarch-repair/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-24T13:43:07-07:00</news:publication_date><news:title>Frozen Elephant Trunk for Acute Type A Aortic Dissection Delivers Durable 20-Year Outcomes and Fewer Late Aortic Events Than Hemiarch Repair</news:title></news:news></url>
</urlset>
